Ventricular assist device in patients with prosthetic heart valves

Artificial Organs

Volumn 34, Issue 11, 2010, Pages 1030-1034

  Mokashi, Suyog A ^a   Schmitto, Jan D ^a   Lee, Lawrence S ^a   Rawn, James D ^a   Bolman III, R Morton ^a   Shekar, Prem S ^a   Couper, Gregory S ^a   Chen, Frederick Y ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bioprosthetic heart valve; Heparin induced thrombocytopenia; Mechanical heart valve; Ventricular assist device

Indexed keywords

ARTIFICIAL HEART; BLOOD VESSELS; FIBER OPTIC SENSORS; HEART; HEART VALVE PROSTHESES; LEFT VENTRICULAR ASSIST DEVICES; VALVES (MECHANICAL);

ANTI-COAGULATION; AORTIC VALVES; BIOPROSTHETIC HEART VALVES; CLINICAL EXPERIENCE; HEPARIN-INDUCED THROMBOCYTOPENIUM; MECHANICAL; MECHANICAL HEART VALVES; PROSTHETIC HEART VALVE; THROMBOCYTOPENIA; VENTRICULAR ASSIST DEVICE;

POLYSACCHARIDES;

HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTICLE; FEMALE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HEART VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL; TREATMENT INDICATION; VENTRICULAR ASSIST DEVICE;

EID: 78649614599     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01102.x     Document Type: Article

References (11)

1. Riegel B, Moser DK, Anker SK, et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation 2009;120:1141-63.
2. Badiwala MV, Rao V. Left ventricular device as destination therapy: are we there yet? Curr Opin Cardiol 2009;24:184-9. Review.
3. Pennington DG, Portner PM, Swartz MT. Clinical experience with the Novacor left ventricular assist system. In: Lewis T, Graham TR, eds. Mechanical Circulatory Support. London: Edward Arnold Publisher, 1995;225-8.
4. Swartz MT, Lowdermilk GA, Moroney DA, McBride LR. Ventricular assist device support in patients with mechanical heart valves. Ann Thorac Surg 1999;68:2248-51.
5. Tisol WB, Mueller DK, Hoy FB, Gomez RC, Clemson BS, Hussain SM. Ventricular assist device use with mechanical heart valves: an outcome series and literature review. Ann Thorac Surg 2001;72:2051-4. discussion 2055. Review.
6. Rao V, Slater JP, Edwards NM, Naka Y, Oz MC. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg 2001;71:1448-53.
7. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach. J Card Surg 1995;10 (Pt 1):288-94.
8. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009;88:1162-70.
9. Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006;25:404-8.
10. Koster A, Huebler S, Potapov E, et al. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg 2007;83:72-6.
11. Christiansen S, Jahn UR, Meyer J, et al. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II. Ann Thorac Surg 2000;69:774-7.